Literature DB >> 11551901

Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras.

S Kampfer1, M Windegger, F Hochholdinger, W Schwaiger, R G Pestell, G Baier, H H Grunicke, F Uberall.   

Abstract

Transcriptional activation of the cyclin D1 by oncogenic Ras appears to be mediated by several pathways leading to the activation of multiple transcription factors which interact with distinct elements of the cyclin D1 promoter. The present investigations revealed that cyclin D1 induction by transforming Ha-Ras is MEK- and Rac-dependent and requires the PKC isotypes epsilon, lambda, and zeta, but not cPKC-alpha. This conclusion is based on observations indicating that cyclin D1 induction by transforming Ha-Ras was depressed in a dose-dependent manner by PD98059, a selective inhibitor of the mitogen-activated kinase kinase MEK-1, demonstrating that Ha-Ras employs extracellular signal-regulated kinases (ERKs) for signal transmission to the cyclin D1 promoter. Evidence is presented that PKC isotypes epsilon and zeta, but not lambda are required for the Ras-mediated activation of ERKs. Expression of kinase-defective, dominant negative (DN) mutants of nPKC-epsilon or aPKC-zeta inhibit ERK activation by constitutively active Raf-1. Phosphorylation within the TEY motif and subsequent activation of ERKs by constitutively active MEK-1 was significantly inhibited by DN aPKC-zeta, indicating that aPKC-zeta functions downstream of MEK-1 in the pathway leading to cyclin D1 induction. In contrast, TEY phosphorylation induced by constitutively active MEK-1 was not effected by nPKC-epsilon, suggesting another position for this kinase within the cascade investigated. Transformation by oncogenic Ras requires activation of several Ras effector pathways which may be PKC-dependent and converge on the cyclin D1 promoter. Therefore, we investigated a role for PKC isotypes in the Ras-Rac-mediated transcriptional regulation of cyclin D1. We have been able to reveal that cyclin D1 induction by oncogenic Ha-Ras is Rac-dependent and requires the PKC isotypes epsilon, lambda, and zeta, but not cPKC-alpha. Evidence is presented that aPKC-lambda acts upstream of Rac, between Ras and Rac, whereas the PKC isotypes epsilon and zeta act downstream of Rac and are required for the activation of ERKs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551901     DOI: 10.1074/jbc.M102047200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

2.  Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.

Authors:  Michele L Scotti; William R Bamlet; Thomas C Smyrk; Alan P Fields; Nicole R Murray
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Protein kinase C isozymes as therapeutic targets for treatment of human cancers.

Authors:  Alan P Fields; Nicole R Murray
Journal:  Adv Enzyme Regul       Date:  2008-03-18

Review 4.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

5.  Requirement of phospholipase D1 activity in H-RasV12-induced transformation.

Authors:  F Gregory Buchanan; Matt McReynolds; Anthony Couvillon; Yoonseok Kam; Vijaykumar R Holla; Raymond N Dubois; John H Exton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

6.  Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions.

Authors:  Fernando Benavides; Jorge Blando; Carlos J Perez; Rachana Garg; Claudio J Conti; John DiGiovanni; Marcelo G Kazanietz
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

7.  Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.

Authors:  John Meshki; M Cecilia Caino; Vivian A von Burstin; Erin Griner; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

8.  Peripheral delivery of a ROCK inhibitor improves learning and working memory.

Authors:  Matthew J Huentelman; Dietrich A Stephan; Joshua Talboom; Jason J Corneveaux; David M Reiman; Jill D Gerber; Carol A Barnes; Gene E Alexander; Eric M Reiman; Heather A Bimonte-Nelson
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

Review 9.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

10.  Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras.

Authors:  T Zhu; T Tsuji; C Chen
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.